☆Samsara BioCapital, LLC
Quality Q
0.884
AUM ($M)
1,217
Positions
24
Turnover
0.12
Top-10 wt
90%
Herfindahl
0.153
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 26 positions · portfolio value $1,217M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆SRRK funds › | SCHOLAR ROCK HLDG CORP | HOLD | — | 31.2% | -1.8% | 379.4 | 6,897,652 | +0 | 5 | — |
| ☆ALMS funds › | ALUMIS INC | HOLD | — | 14.7% | +1.1% | 178.6 | 6,345,219 | +0 | 5 | — |
| ☆MLYS funds › | MINERALYS THERAPEUTICS INC | HOLD | — | 13.0% | -2.4% | 158.4 | 5,871,018 | +0 | 5 | — |
| ☆SEPN funds › | SEPTERNA INC | HOLD | — | 8.7% | +1.3% | 105.5 | 3,149,128 | +0 | 5 | — |
| ☆ALMR funds › | ALAMAR BIOSCIENCES INC | NEW | — | 5.5% | +5.5% | 67.2 | 2,480,310 | +2,480,310 | 1 | — |
| ☆NGNE funds › | NEUROGENE INC | HOLD | — | 4.4% | +1.1% | 54.0 | 1,717,127 | +0 | 5 | — |
| ☆KLRS funds › | KALARIS THERAPEUTICS INC | TRIM | — | 4.3% | -3.0% | 52.4 | 12,881,175 | -66,906 | 5 | — |
| ☆SGP funds › | SPYGLASS PHARMA INC | HOLD | — | 3.9% | -1.5% | 47.0 | 2,109,953 | +0 | 2 | — |
| ☆STRO funds › | SUTRO BIOPHARMA INC | HOLD | — | 2.9% | +0.3% | 35.3 | 1,062,872 | +0 | 3 | — |
| ☆IVA funds › | INVENTIVA SA | ADD | — | 2.0% | -0.8% | 23.9 | 6,314,805 | +1,120,000 | 3 | — |
| ☆JBIO funds › | JADE BIOSCIENCES INC | TRIM | — | 1.3% | +0.0% | 16.4 | 736,237 | -232,561 | 5 | — |
| ☆PBLS funds › | PARABILIS MEDICINES INC | NEW | — | 1.3% | +1.3% | 15.2 | 556,044 | +556,044 | 1 | — |
| ☆VTVT funds › | VTV THERAPEUTICS INC | HOLD | — | 0.9% | -0.2% | 11.2 | 298,496 | +0 | 5 | — |
| ☆AQST funds › | AQUESTIVE THERAPEUTICS INC | HOLD | — | 0.9% | -0.2% | 10.4 | 2,500,000 | +0 | 4 | — |
| ☆CUSIP:65487U108 funds › | NKARTA INC | HOLD | — | 0.8% | +0.1% | 9.9 | 3,507,666 | +0 | 5 | — |
| ☆ARTV funds › | ARTIVA BIOTHERAPEUTICS INC | NEW | — | 0.8% | +0.8% | 9.3 | 954,861 | +954,861 | 1 | — |
| ☆RANI funds › | RANI THERAPEUTICS HLDGS INC | ADD | — | 0.6% | +0.0% | 7.9 | 10,369,159 | +1,869,159 | 3 | — |
| ☆AGMB funds › | AGOMAB THERAPEUTICS NV | HOLD | — | 0.6% | +0.0% | 7.8 | 600,000 | +0 | 2 | — |
| ☆ABVX funds › | ABIVAX SA | TRIM | — | 0.6% | -0.0% | 7.3 | 55,095 | -1,486 | 4 | — |
| ☆XFOR funds › | X4 PHARMACEUTICALS INC | TRIM | — | 0.5% | -0.2% | 6.5 | 1,395,587 | -436,979 | 3 | — |
| ☆ELOX funds › | ELOXX PHARMACEUTICALS INC | NEW | — | 0.5% | +0.5% | 5.6 | 400,000 | +400,000 | 1 | — |
| ☆CHRS funds › | COHERUS ONCOLOGY INC | HOLD | — | 0.4% | -0.2% | 4.8 | 3,428,571 | +0 | 2 | — |
| ☆UPB funds › | UPSTREAM BIO INC | TRIM | — | 0.2% | -0.4% | 2.4 | 353,717 | -382,330 | 5 | — |
| ☆GOSS funds › | GOSSAMER BIO INC | HOLD | — | 0.1% | -0.1% | 1.2 | 7,222,559 | +0 | 5 | — |
| ☆PVLA funds › | PALVELLA THERAPEUTICS INC NE | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -38,432 | 0 | — |
| ☆CUSIP:03940C100 funds › | ARCELLX INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -60,873 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 1,217 | 24 | 0.12 | 90% | 0.153 | 0.883 | — | in |
| 2026Q1 | 1,029 | 22 | 0.19 | 92% | 0.168 | 0.811 | — | in |
| 2025Q4 | 969 | 21 | 0.17 | 92% | 0.175 | 0.785 | — | in |
| 2025Q3 | 766 | 27 | 0.23 | 89% | 0.189 | 0.648 | — | in |
| 2025Q2 | 489 | 29 | 0.18 | 88% | 0.206 | 0.698 | — | entered |
| 2025Q1 | 561 | 37 | 0.00 | 86% | 0.165 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status